Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|
Free Cash Flow margin | (214.9%) | (92.8%) | (4.5%) | (14.5%) | (6.4%) | 5.4% |
Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|
% growth | 26.7 0.0% | 82.6 209.4% | 148.8 80.2% | 271.9 82.8% | 526.9 93.8% | 872.0 65.5% |
Cost of Goods Sold (COGS) | 18.9 | 38.0 | 39.3 | 67.4 | 118.2 | 157.1 |
% margin | 7.8 29.2% | 44.6 54.0% | 109.5 73.6% | 204.5 75.2% | 408.7 77.6% | 714.9 82.0% |
Operating Expenses | 83.6 | 119.0 | 124.6 | 319.5 | 477.4 | 744.4 |
Research & Development Expenses (R&D) | 0.0 | 0.0 | 11.2 | 22.4 | 29.2 | 48.2 |
Selling, General & Administrative Expenses (SG&A) | 83.6 | 119.0 | 124.6 | 319.5 | 370.8 | 692.7 |
% margin | (75.8) (284.0%) | (74.4) (90.1%) | (15.1) (10.2%) | (115.0) (42.3%) | (68.7) (13.0%) | (29.5) (3.4%) |
Interest Income | 0.6 | 1.9 | 0.4 | 0.4 | 2.6 | 0.0 |
Interest Expense | 0.0 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 |
Pre-tax Income | (75.2) | (72.0) | (18.0) | (110.8) | (65.7) | (21.6) |
% effective tax rate | 0.0 (0.0%) | 0.1 (0.1%) | 0.1 (0.7%) | (3.1) 2.8% | (0.0) 0.0% | 2.0 (9.2%) |
% margin | (75.2) (282.0%) | (72.1) (87.3%) | (18.1) (12.2%) | (107.7) (39.6%) | (65.7) (12.5%) | (23.5) (2.7%) |
EPS | (1.12) | (2.86) | (0.51) | (0.58) | (0.32) | (0.11) |
Diluted EPS | (1.12) | (2.86) | (0.51) | (0.58) | (0.32) | (0.11) |
% margin | 0.0 0.0% | (74.2) (89.8%) | (14.1) (9.5%) | (111.0) (40.8%) | (61.2) (11.6%) | (19.9) (2.3%) |
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
As of today, Microsoft Corp's last 12-month Free Cash Flow margin is 13.4%, based on the financial report for Dec 31, 2024 (Q4’2024). The average annual Free Cash Flow margin for Hims & Hers Health, Inc. have been (2.0%) over the past three years, and (12.6%) over the past five years.
As of today, Hims & Hers Health, Inc.'s Free Cash Flow margin is 13.4%, which is higher than industry median of 5.9%. It indicates that Hims & Hers Health, Inc.'s Free Cash Flow margin is Good.